T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Bath & Body Works
BBWI
$3.65B
| $131M | 0.02% |
6,221,470
+16,128
| +0.3% | +$319K |
|
577
Guidewire Software
GWRE
$14.4B
| $131M | 0.02% |
1,292,575
-292,010
| -18% | -$29.8M |
|
|
GOOS
578
Canada Goose Holdings
GOOS
$844M
| $129M | 0.02% |
3,336,826
-2,528,668
| -43% | -$114M |
|
579
US Physical Therapy
USPH
$1.22B
| $129M | 0.02% |
1,054,313
+263
| +0% | +$30.2K |
|
580
Kilroy Realty
KRC
$4.22B
| $129M | 0.02% |
1,749,286
-113,019
| -6% | -$8.59M |
|
581
Enanta Pharmaceuticals
ENTA
$393M
| $129M | 0.02% |
1,528,541
+159,504
| +12% | +$14.3M |
|
582
HEICO Corp Class A
HEI.A
$38B
| $128M | 0.02% |
1,239,123
-204,180
| -14% | -$18.8M |
|
583
Compañía de Minas Buenaventura
BVN
$8.79B
| $128M | 0.02% |
7,668,436
-220,369
| -3% | -$3.49M |
|
584
Moody's
MCO
$82.8B
| $128M | 0.02% |
653,663
-2,542
| -0.4% | -$482K |
|
|
PGRE
585
DELISTED
Paramount Group
PGRE
| $128M | 0.02% |
9,108,427
-3,335,997
| -27% | -$48.1M |
|
586
Ionis Pharmaceuticals
IONS
$9.39B
| $128M | 0.02% |
1,985,367
-482,102
| -20% | -$34.1M |
|
587
Live Nation Entertainment
LYV
$43.2B
| $127M | 0.02% |
1,914,072
+25,792
| +1% | +$1.66M |
|
588
Palo Alto Networks
PANW
$315B
| $126M | 0.02% |
3,723,906
+2,774,682
| +292% | +$104M |
|
589
Boston Properties
BXP
$10.8B
| $126M | 0.02% |
973,871
-199,125
| -17% | -$26.7M |
|
590
AutoZone
AZO
$49.7B
| $124M | 0.02% |
113,214
-2,389
| -2% | -$2.51M |
|
|
MRTX
591
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $124M | 0.02% |
1,206,144
+388,516
| +48% | +$30.2M |
|
592
St. Joe Company
JOE
$3.87B
| $124M | 0.02% |
7,184,975
+130,255
| +2% | +$2.18M |
|
593
Edgewell Personal Care
EPC
$1.32B
| $124M | 0.02% |
4,586,719
-256,313
| -5% | -$9.14M |
|
|
IAA
594
DELISTED
IAA, Inc. Common Stock
IAA
| $123M | 0.02% |
+3,177,901
| New | +$123M |
|
595
Grupo Aeroportuario del Sureste
ASR
$8.24B
| $123M | 0.02% |
758,469
+9,862
| +1% | +$1.61M |
|
596
Hanover Insurance
THG
$7.74B
| $123M | 0.02% |
956,682
-81,329
| -8% | -$9.88M |
|
597
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $122M | 0.02% |
+1,395,000
| New | +$120M |
|
598
Host Hotels & Resorts
HST
$15.6B
| $121M | 0.02% |
6,665,866
-66,082
| -1% | -$1.25M |
|
599
SouthState Bank Corp
SSB
$10.7B
| $121M | 0.02% |
1,635,825
+22,349
| +1% | +$1.61M |
|
600
Moog Inc Class A
MOG.A
$13.6B
| $120M | 0.02% |
1,278,955
-2,517
| -0.2% | -$224K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.